BioTelemetry Stock News

HeartBeam Inc (BEAT) shares closed today at 0.5% above its 52 week low of $3.85, giving the company a market cap of $32M. The stock is currently down 11.7% year-to-date, down 11.7% over the past 12 months, and down 11.7% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 31.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 403.2% The company's stock price performance over the past 12 months lags the peer average by -285.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Data Bridge Market research presents the top quality and comprehensive Telehealth research report which provides clear insights into market dynamics and prospects the whole market including global production, revenue forecast, value and volume. This Telehealth report deeply study

Overview of Global Patient Monitoring Device/System/Equipment Market: An influential Patient Monitoring Device/System/Equipment Market analysis report provides the right information at the fingertips which is the key to making faster and more informed decisions. The report can get accurate, in-depth information on

Digital Health Technologies Market report is an established source of information that presents with a telescopic view of the current market trends, situations, opportunities and status. Moreover, this market report gives idea to clients about the market drivers and restraints

Major wearable cardiac devices market players include Welch Allyn, iRhythm technologies, VitalConnect, ZOLL medical corporation, Biotelemetry Inc., Quardio Inc., Cardiac Rhythm and Proteus Digital…

A heart health innovator went public yesterday. Here's why you shouldn't be worried by the turbulence of the HeartBeam IPO.

Philips (PHG) enters into a deal to acquire BioTelemetry, which drives the expansion of its cardiac care portfolio and fuels customer acquisition.

NEW YORK, Dec. 19, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: BioTelemetry, Inc. (NASDAQ: BEAT) concerning potenti

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioTelemetry, Inc. ("BioTelemetry" or

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York C

NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of BioTelemet

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by BioTelemetry, Inc. (NASDAQ: BEAT) and its board of directors concerning the proposed acq

BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for $2.8 billion. BioTelemetry is a Pennsylvania-based medical

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of BioTelemetry, Inc. (NASDAQ: BEAT) to Royal Philips for $72.00 per share in cash is